Current through Register Vol. 35, No. 18, September 24, 2024
A.
OPIOIDS: Unless specifically excepted or unless in another
schedule any of the following opioids, including its isomers, esters, ethers,
salts and salts of isomers, esters, and ethers whenever the existence of such
isomers, esters, ethers, and salts is possible within the specific chemical
designation except dextro and levopropoxyphene.
(1) Alphaprodine;
(2) Anileridine;
(3) Bezitramide;
(4) Diphenoxylate;
(5) Dihydrocodeine;
(6) Dextropropoxyphene (bulk) non-dosage
form;
(7) Fentanyl;
(8) Isomethadone;
(9) Levomethorphan;
(10) Levorphanol;
(11) Metazocine;
(12) Methadone;
(13) 4-cyano-2-dimethylamino-4,
4-diphenylbutane;
(14)
Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-dipehyl-propane-carboxylic
acid;
(15) Pethidine;
(16)
4-cyano-1-methyl-4-phenylpiperidine;
(17)
ethyl-4-phenyl-piperdine-4-carboxylate;
(18) 1-methyl-4-phenylpiperidine-4-carboxylic
acid;
(19) Phenazocine;
(20) Piminodine;
(21) Racemethorphan;
(22) Racemorphan;
(23) Sufentanil;
(24) Carfentanil;
(25) (LAAM); Levo-alphacetylmethadol;
(26) Tapentadol;
(27) Thiafentanil;
(28) Norfentanyl;
(29) Oliceridine.
B. Shall consist of the drugs and other
substances, by whatever official name, common or usual name, chemical name or
brand name designated, listed in this section. Substance, vegetable origin or
chemical synthesis. Unless specifically exempt or unless listed in another
schedule, any of the following substances whether produced directly or
indirectly by extraction from substances of vegetable origin, or independently
by means of chemical synthesis, or by a combination of extraction and chemical
synthesis.
(1) Opium and opiate, and any
salts, compound, derivative, or preparation of opium or opiate excluding
naloxone, dextrorphan, nalbuphine, naltrexone and apomorphine but including the
following:
(a) Raw opium;
(b) Opium extracts;
(c) Opium fluid extracts;
(d) Powdered opium;
(e) Granulated opium;
(f) Tincture of opium;
(g) Codeine;
(h) Ethylmorphine;
(i) Etorphine hydrochloride;
(j) Hydrocodone;
(k) Hydromorphone;
(l) Metopon;
(m) Morphine;
(n) Oxycodone;
(o) Oxymorphone;
(p) Thebaine;
(q) Alfentanil;
(r) Oripavine.
(2) Any salt, compound derivative, or
preparation thereof, which is chemically equivalent or identical with any of
the substances referred to in Paragraph (1) of Subsection A of
16.19.20.66 NMAC, except that
these substances shall not include the isoquinoline alkaloids of
opium.
(3) Opium poppy and poppy
straw.
(4) Coca leaves and any
salt, compound, derivative or preparation of coca leaves and any salt,
compound, derivative or preparation thereof which is chemically equivalent or
identical with any of these substances, except that the substances shall not
include de-cocainized coca leaves or extraction of coca leaves, which
extractions do not contain cocaine or ecgonine.
C.
STIMULANTS: Unless
specifically exempt or unless listed in another schedule, any material,
compound, mixture or preparation which contains any quantity of the following
substances having a stimulant effect on the central nervous system. (See
16.19.21 NMAC- Drug Precursors)
(1)
Amphetamine, its salts, optical isomers and salts of its optical
isomers.
(2) Methamphetamine, its
salts, isomers and salts of isomers.
(3) Phenmetrazine and its salts.
(4) Methylphenidate.
(5) Lisdexamfetamine.
D.
DEPRESSANTS: Unless
specifically exempt or unless listed in another schedule any material, compound
mixture or preparation which contains any quantity of the substance having a
depressant effect on the central nervous system, including its salts, isomers
and salts of isomers is possible within the specific chemical designation.
(1) Amobarbital;
(2) Secobarbital;
(3) Pentobarbital;
(4) Phencyclidine;
(5) Glutethimide;
(6) 1-phenylcyclohexylamine;
(7)
1-piperidinocyclohexanecarbonitrile;
(8) Dronabinol in an oral solution in a drug
product approved for marketing by the U.S. Food and Drug
Administration.
E.
HALLUCINOGENIC SUBSTANCES: Unless specifically exempt or unless
listed in another schedule, any material, compound, mixture or preparation,
which contains any quantity of the following hallucinogenic substances, or
which contains any of its salts, isomers and salts of isomers whenever the
existence of such salts, isomers, and salts of isomers is possible within the
specific chemical designation (for purpose of this paragraph only, the term
"isomers" includes the optical, positional, and geometric isomers):
(1) Nabilone;
(2) Phenylacetone (P2P, benzyl methyl ketone;
methyl benzyl ketone).
F.
MISCELLANEOUS:
(1) Dihydroetorphine;
(2) Bulk dextropropoxyphene;
(3) Remifentanil.
